DSM-Firmenich AG provides nutrition, health, and beauty solutions in Switzerland, the Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia. The company operates t…
Industry Peers
Specialty Chemicals| Headline | Source | Time |
|---|---|---|
This week | ||
DDe Tijd | ||
Older | ||
 Fine Fragrance’s Sweet Smell of Success Lasts The recent spate of suppliers’ results shows the category remains robust. | ||
 DSM-Firmenich Medisca Deal Highlights U.S. Vitamin API And Valuation Upside DSM-Firmenich (ENXTAM:DSFIR) has partnered with Medisca to expand access to pharmaceutical-grade vitamin active pharmaceutical ingredients in the U.S. market. The agreement focuses on supplying European-manufactured vitamin APIs to U.S. pharmaceutical compounding pharmacies. The partnership aims to broaden distribution channels and support higher quality standards in customized medications. For DSM-Firmenich, a company active in nutrition, health and beauty, this partnership provides a more... | ||
Bbeleggersvereniging VEB | ||
Dividend Investors: Don't Be Too Quick To Buy DSM-Firmenich AG (AMS:DSFIR) For Its Upcoming Dividend It looks like DSM-Firmenich AG ( AMS:DSFIR ) is about to go ex-dividend in the next 3 days. The ex-dividend date... | ||
Assessing DSM-Firmenich (ENXTAM:DSFIR) Valuation After Recent Share Price Swings Why DSM-Firmenich Shares Are Back On Investors’ Radar DSM-Firmenich (ENXTAM:DSFIR) has come into focus after recent share performance, with the stock showing a 0.1% move over the past week but a weaker pattern over the month and past 3 months. See our latest analysis for DSM-Firmenich. That 6.35% 1 day share price return has come after a weaker spell, with the 30 day share price return of 16.4% and year to date share price return of 14.38%, while the 1 year total shareholder return of 36.91%... | ||
DSM-Firmenich AG (AMS:DSFIR) Analysts Are Reducing Their Forecasts For This Year One thing we could say about the analysts on DSM-Firmenich AG ( AMS:DSFIR ) - they aren't optimistic, having just made... | ||
DSM-Firmenich AG (DSMFF) Full Year 2025 Earnings Call Highlights: Navigating Growth Amid Market ... Despite cautious consumer behavior and margin pressures, DSM-Firmenich AG (DSMFF) reports steady growth and sustainability achievements. | ||
Assessing DSM Firmenich (ENXTAM:DSFIR) Valuation After Recent Share Price Rebound What DSM-Firmenich’s Recent Share Performance Signals for Investors DSM-Firmenich (ENXTAM:DSFIR) has drawn attention after recent share price moves, with a 1-day return of 0.06% and roughly 4% gain over the past month, contrasting with a 28% decline over the past year. See our latest analysis for DSM-Firmenich. The recent 1-day share price return of 5.51% has eased some pressure after a weaker 90-day share price return of 4.34% and a 1-year total shareholder return decline of 27.94%,... | ||
Is It Time To Consider Buying DSM-Firmenich AG (AMS:DSFIR)? Let's talk about the popular DSM-Firmenich AG ( AMS:DSFIR ). The company's shares saw significant share price movement... | ||
Retail investors account for 60% of DSM-Firmenich AG's (AMS:DSFIR) ownership, while institutions account for 34% Key Insights Significant control over DSM-Firmenich by retail investors implies that the general public has more power... | ||